These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7479558)

  • 1. The distribution of oleic acid between salbutamol base drug and different propellant blends.
    Eriksson PM; Sandström KB; Rosenholm JB
    Pharm Res; 1995 May; 12(5):715-9. PubMed ID: 7479558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microcalorimetric investigation of the interaction of surfactants with crystalline and partially crystalline salbutamol sulphate in a model inhalation aerosol system.
    Blackett PM; Buckton G
    Pharm Res; 1995 Nov; 12(11):1689-93. PubMed ID: 8592671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophoretic mobility of salbutamol drug powder in mixed propellant solvents.
    Sandström KB; Eriksson PM; Rosenholm JB
    J Pharm Sci; 1994 Oct; 83(10):1380-5. PubMed ID: 7884654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of small amorphous amounts in hydrophilic and hydrophobic APIs on storage stability of dry powder inhalation products.
    Müller T; Krehl R; Schiewe J; Weiler C; Steckel H
    Eur J Pharm Biopharm; 2015 May; 92():130-8. PubMed ID: 25769680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers.
    Schroeter JD; Sheth P; Hickey AJ; Asgharian B; Price OT; Holt JT; Conti DS; Saluja B
    AAPS PharmSciTech; 2018 Jul; 19(5):2335-2345. PubMed ID: 29858973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an impinging jet for dispersion of dry powder inhalation aerosols.
    Wang Z; Lange CF; Finlay WH
    Int J Pharm; 2004 May; 275(1-2):123-31. PubMed ID: 15081143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
    Wu L; Al-Haydari M; da Rocha SR
    Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of temperature on the emitted dose of an oral metered dose inhaler.
    Williams RO; Barron MK
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1043-8. PubMed ID: 9876558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of the Raman spectra and hygroscopicity of four pharmaceutical aerosols as they travel from pressurised metered dose inhalers (pMDI) to a model lung.
    Davidson N; Tong HJ; Kalberer M; Seville PC; Ward AD; Kuimova MK; Pope FD
    Int J Pharm; 2017 Mar; 520(1-2):59-69. PubMed ID: 28159683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
    Schiavone H; Palakodaty S; Clark A; York P; Tzannis ST
    Int J Pharm; 2004 Aug; 281(1-2):55-66. PubMed ID: 15288343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of Bipolar Charge Analyzer (BOLAR) in Characterizing the Bipolar Electrostatic Charge Profile of Commercial Metered Dose Inhalers (MDIs).
    Leung SS; Chiow AC; Ukkonen A; Chan HK
    Pharm Res; 2016 Feb; 33(2):283-91. PubMed ID: 26337773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions.
    Dalby RN; Byron PR
    Pharm Res; 1988 Jan; 5(1):36-9. PubMed ID: 3244606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid interrogation of the physical and chemical characteristics of salbutamol sulphate aerosol from a pressurised metered-dose inhaler (pMDI).
    Tong HJ; Fitzgerald C; Gallimore PJ; Kalberer M; Kuimova MK; Seville PC; Ward AD; Pope FD
    Chem Commun (Camb); 2014 Dec; 50(98):15499-502. PubMed ID: 25329335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug form selection in albuterol-containing metered-dose inhaler formulations and its impact on chemical and physical stability.
    Tzou TZ; Pachuta RR; Coy RB; Schultz RK
    J Pharm Sci; 1997 Dec; 86(12):1352-7. PubMed ID: 9423144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P; Du J; Smyth HDC
    J Pharm Sci; 2017 Jan; 106(1):366-376. PubMed ID: 27939234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic electrostatic charge of lactose-salbutamol sulphate powder blends dispersed from a Cyclohaler®.
    Hoe S; Young PM; Traini D
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1365-75. PubMed ID: 21554161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of mechanical activation on the physical stability of salbutamol sulphate.
    Brodka-Pfeiffer K; Langguth P; Grass P; Häusler H
    Eur J Pharm Biopharm; 2003 Nov; 56(3):393-400. PubMed ID: 14602182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model for predicting size distributions delivered from pMDIs with suspended drug.
    Stein SW; Sheth P; Myrdal PB
    Int J Pharm; 2012 Jan; 422(1-2):101-15. PubMed ID: 22044537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.